Skip to main content
. Author manuscript; available in PMC: 2011 Nov 2.
Published in final edited form as: Chembiochem. 2010 Nov 2;11(16):2302–2310. doi: 10.1002/cbic.201000399

Figure 3.

Figure 3

Normalized inhibition curves for A) monomeric guanidinoneomycin 1 and B) dimeric guanidinoneomycin 2. See Scheme 4 for structures of glycans A–G.[52] Key: heparin (red), de 2-O sulfated heparin (green), de 6-O sulfated heparin (navy), de O sulfated heparin (purple), N-Acetylated heparin (orange), carboxy reduced heparin (pink), and dermatan sulfate (teal).